 Randee Sedaka
Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sodium Chloride, Dietary | 6 | 2024 | 31 | 1.350 |
Why?
| | Histone Deacetylase 1 | 3 | 2024 | 24 | 0.980 |
Why?
| | TRPP Cation Channels | 2 | 2024 | 79 | 0.940 |
Why?
| | Kidney | 5 | 2024 | 1383 | 0.900 |
Why?
| | Natriuresis | 2 | 2020 | 10 | 0.880 |
Why?
| | Kidney Tubules, Collecting | 2 | 2020 | 30 | 0.870 |
Why?
| | Nitric Oxide | 5 | 2024 | 896 | 0.820 |
Why?
| | Renal Elimination | 1 | 2020 | 6 | 0.710 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 1 | 2024 | 254 | 0.710 |
Why?
| | Intestinal Mucosa | 1 | 2024 | 593 | 0.640 |
Why?
| | Mice, Knockout | 5 | 2024 | 2888 | 0.360 |
Why?
| | Kidney Medulla | 2 | 2020 | 34 | 0.340 |
Why?
| | Blood Pressure | 6 | 2025 | 1736 | 0.310 |
Why?
| | Receptor, Endothelin B | 4 | 2020 | 50 | 0.300 |
Why?
| | Disease Models, Animal | 5 | 2025 | 4077 | 0.290 |
Why?
| | Kidney Diseases | 2 | 2021 | 382 | 0.250 |
Why?
| | Rats, Sprague-Dawley | 4 | 2024 | 2403 | 0.240 |
Why?
| | Endothelin-1 | 3 | 2022 | 180 | 0.240 |
Why?
| | Permeability | 1 | 2024 | 158 | 0.230 |
Why?
| | Signal Transduction | 6 | 2024 | 4935 | 0.220 |
Why?
| | Animals | 15 | 2025 | 35409 | 0.210 |
Why?
| | Polycystic Kidney Diseases | 1 | 2024 | 68 | 0.210 |
Why?
| | Mice | 8 | 2025 | 16983 | 0.210 |
Why?
| | Fasting | 1 | 2025 | 268 | 0.200 |
Why?
| | Sirolimus | 1 | 2024 | 270 | 0.200 |
Why?
| | Antisickling Agents | 1 | 2021 | 7 | 0.180 |
Why?
| | Sodium Chloride | 1 | 2022 | 138 | 0.180 |
Why?
| | p21-Activated Kinases | 1 | 2021 | 15 | 0.180 |
Why?
| | Hydroxyurea | 1 | 2021 | 35 | 0.180 |
Why?
| | Nitric Oxide Synthase Type I | 1 | 2020 | 28 | 0.180 |
Why?
| | Circadian Clocks | 1 | 2021 | 46 | 0.170 |
Why?
| | Electrolytes | 1 | 2020 | 59 | 0.170 |
Why?
| | Nanoparticles | 1 | 2024 | 376 | 0.170 |
Why?
| | ARNTL Transcription Factors | 1 | 2020 | 17 | 0.170 |
Why?
| | Hepatocytes | 1 | 2021 | 215 | 0.160 |
Why?
| | Protein Deglycase DJ-1 | 1 | 2019 | 11 | 0.160 |
Why?
| | Uncoupling Protein 2 | 1 | 2019 | 8 | 0.160 |
Why?
| | Taurochenodeoxycholic Acid | 1 | 2018 | 9 | 0.160 |
Why?
| | Mice, Inbred C57BL | 4 | 2025 | 5468 | 0.150 |
Why?
| | Histone Deacetylases | 1 | 2020 | 212 | 0.150 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2020 | 209 | 0.150 |
Why?
| | GTP Cyclohydrolase | 1 | 2018 | 8 | 0.150 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2021 | 270 | 0.150 |
Why?
| | Reactive Nitrogen Species | 1 | 2018 | 21 | 0.150 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2020 | 207 | 0.150 |
Why?
| | Male | 13 | 2025 | 63759 | 0.140 |
Why?
| | Receptors, Estrogen | 1 | 2020 | 422 | 0.140 |
Why?
| | Anemia, Sickle Cell | 1 | 2021 | 253 | 0.140 |
Why?
| | Disease Progression | 1 | 2024 | 2628 | 0.140 |
Why?
| | Adipose Tissue | 1 | 2021 | 594 | 0.130 |
Why?
| | Liver Neoplasms | 1 | 2021 | 636 | 0.120 |
Why?
| | Reactive Oxygen Species | 1 | 2018 | 592 | 0.120 |
Why?
| | Glioblastoma | 1 | 2018 | 322 | 0.120 |
Why?
| | Neoplastic Stem Cells | 1 | 2018 | 378 | 0.110 |
Why?
| | Liver | 1 | 2021 | 1839 | 0.100 |
Why?
| | Cardiovascular Diseases | 1 | 2025 | 2008 | 0.100 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2018 | 957 | 0.100 |
Why?
| | Obesity | 1 | 2025 | 2885 | 0.090 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2545 | 0.080 |
Why?
| | Hypertension | 1 | 2019 | 1242 | 0.080 |
Why?
| | Sodium | 2 | 2022 | 205 | 0.080 |
Why?
| | Potassium | 2 | 2020 | 144 | 0.080 |
Why?
| | Brain Neoplasms | 1 | 2018 | 1149 | 0.080 |
Why?
| | Rats | 3 | 2024 | 5487 | 0.080 |
Why?
| | Inflammation | 1 | 2018 | 2748 | 0.070 |
Why?
| | Mice, Obese | 1 | 2025 | 63 | 0.060 |
Why?
| | Sex Factors | 2 | 2020 | 1973 | 0.050 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2021 | 1327 | 0.050 |
Why?
| | Microvessels | 1 | 2024 | 82 | 0.050 |
Why?
| | Diet, High-Fat | 1 | 2025 | 239 | 0.050 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2024 | 398 | 0.050 |
Why?
| | Circadian Rhythm | 1 | 2025 | 416 | 0.050 |
Why?
| | Drug Delivery Systems | 1 | 2024 | 337 | 0.040 |
Why?
| | Hemoglobin, Sickle | 1 | 2021 | 18 | 0.040 |
Why?
| | Hemoglobin A | 1 | 2021 | 22 | 0.040 |
Why?
| | Arginase | 1 | 2021 | 32 | 0.040 |
Why?
| | Histone Deacetylase 2 | 1 | 2020 | 10 | 0.040 |
Why?
| | Proteinuria | 1 | 2021 | 91 | 0.040 |
Why?
| | Apoptosis | 2 | 2021 | 2489 | 0.040 |
Why?
| | Water-Electrolyte Balance | 1 | 2020 | 34 | 0.040 |
Why?
| | Heterografts | 1 | 2021 | 134 | 0.040 |
Why?
| | Acclimatization | 1 | 2022 | 166 | 0.040 |
Why?
| | Cyclopentanes | 1 | 2020 | 19 | 0.040 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2021 | 203 | 0.040 |
Why?
| | Receptor, Endothelin A | 1 | 2020 | 63 | 0.040 |
Why?
| | Aldosterone | 1 | 2020 | 43 | 0.040 |
Why?
| | Vascular Stiffness | 1 | 2025 | 467 | 0.040 |
Why?
| | Benzamides | 1 | 2020 | 203 | 0.040 |
Why?
| | Ovariectomy | 1 | 2020 | 137 | 0.040 |
Why?
| | Chaperonin 60 | 1 | 2019 | 14 | 0.040 |
Why?
| | Mice, 129 Strain | 1 | 2019 | 87 | 0.040 |
Why?
| | Quinolines | 1 | 2020 | 156 | 0.040 |
Why?
| | Cisplatin | 1 | 2021 | 299 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2024 | 749 | 0.040 |
Why?
| | Hemoglobins | 1 | 2021 | 339 | 0.040 |
Why?
| | Hyaluronan Receptors | 1 | 2018 | 97 | 0.040 |
Why?
| | Random Allocation | 1 | 2018 | 347 | 0.040 |
Why?
| | Endothelium, Vascular | 1 | 2024 | 902 | 0.040 |
Why?
| | Animals, Genetically Modified | 1 | 2018 | 231 | 0.040 |
Why?
| | Estrogens | 1 | 2020 | 348 | 0.030 |
Why?
| | Gene Deletion | 1 | 2018 | 380 | 0.030 |
Why?
| | Mitochondrial Proteins | 1 | 2019 | 247 | 0.030 |
Why?
| | Pyridines | 1 | 2020 | 478 | 0.030 |
Why?
| | Estradiol | 1 | 2020 | 494 | 0.030 |
Why?
| | Homeostasis | 1 | 2020 | 605 | 0.030 |
Why?
| | Carcinogenesis | 1 | 2018 | 214 | 0.030 |
Why?
| | Female | 5 | 2022 | 68829 | 0.030 |
Why?
| | Mice, Nude | 1 | 2018 | 680 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2018 | 931 | 0.030 |
Why?
| | Up-Regulation | 1 | 2019 | 836 | 0.030 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2021 | 753 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2018 | 590 | 0.030 |
Why?
| | Gene Expression | 1 | 2021 | 1465 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2021 | 2135 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2018 | 808 | 0.030 |
Why?
| | Diet | 1 | 2022 | 1212 | 0.030 |
Why?
| | Survival Rate | 1 | 2018 | 1872 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2021 | 2378 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2019 | 1264 | 0.020 |
Why?
| | Humans | 5 | 2022 | 129847 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 3773 | 0.020 |
Why?
| | Aged | 1 | 2021 | 22107 | 0.010 |
Why?
| | Middle Aged | 1 | 2021 | 31177 | 0.010 |
Why?
| | Adult | 1 | 2021 | 35634 | 0.010 |
Why?
|
|
Sedaka's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|